ARCHIVES

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.”

July 29, 2005

In Brief: DCCR Advisory Committee Meeting Rescheduled; Durant To Head Cooperative Group Chairman

June 29, 1979

BRCA Mutations In About 2% Of Breast Cancer Patients

August 25, 2006

NSABP Researcher Committed Misconduct, NIH Investigation Finds

March 18, 1994

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001

Five Awards Expected In Annual CCP Review; 21 Applicants Compete For Limited Funding

February 1, 1991